The U.S. FDA finalized a guidance for third-party servicing of medical devices, which helps to clarify the distinction ...

In a research collaboration that could bring in up to $600 million, Metaphore Biotechnologies Inc. has become the third ...

Prenatal therapies are the next disruptive technologies in health care, which will advance and shape the future of patient ...

Three years ago when Keting Chu pondered the name for a new biopharma company that would fold in infectious disease assets from Novartis AG, she looked out over her West Coast backyard. “I was looking ...